The preventive role of diet in prostatic disease

British Journal of Urology

Volumn 77, Issue 4, 1996, Pages 481-493

  Morton, M S ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; DIET; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE DISEASE; REVIEW;

EID: 0029920587     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1996.09361.x     Document Type: Review

References (149)

1. Wynder E, Gori G. Contribution of the environment to cancer incidence: an epidemiologic study. J Natl Can Inst 1977; 58: 825-32
2. Higginson J, Muir C. Environmental carcinogenesis: misconceptions and limitations to cancer control. J Natl Can Inst 1979; 63: 1291-8
3. Doll R. Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Can Inst 1981; 66: 1191-308
4. Hill MJ. Dietary fat and human cancer (review). Anticancer Res 1987; 7: 281-92
5. Miller AB, Berrino F, Hill M, Pietinen P, Riboli E, Wahrendorf J. Diet in the aetiology of cancer: a review. Eur J Cancer 1994; 30: 207-20
6. Haenzel W, Kurihara M. Studies of Japanese migrants. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 1968; 40: 43-68
7. Buell P. Changing incidence of breast cancer in JapaneseAmerican women. J Natl Cancer Inst 1973; 51: 1479-83
8. Shimizu H. Ropp RK. Bernstein L, Yatani R, Henderson BE, Mack TH. Cancers of the breast and prostate among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991; 63: 963-6
9. Skrabanek P. Invited viewpoints. Eur J Cancer 1994; 30: 220-1
10. McMichael AJ. Invited viewpoints. Eur J Cancer 1994; 30: 221-3
11. Anon. Diet and breast cancer. Nature 1992; 359: 76
12. Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand }Clin Lab Invest 1990; 50: (suppl. 201) 3-23
13. Slavin JL. Epidemiological evidence for the impact of whole grains on health. Crit Rev in Food Sci Nutr 1994; 34: 427-34
14. Armstrong BE, Doll R. Environmental factors and cancer incidence and mortality in different countries with special reference to dietary practices. Int J Cancer 1975; 15: 617-31
15. Silverberg E. Boring CC, Squires TS. Cancer statistics. A Cancer Journal for Clinicians 1990; 40: 9-26
16. Zaridze DG, Boyle P, Smans M. International trends in prostatic cancer. Int J Cancer 1984; 33: 223-230
17. Sondik E. Incidence, survival and mortality trends in prostate cancer in the United States. In Coffey DS, Resnick MI, Dorr FA. Karr JP eds, A Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer. New York: Plenum Press, 1981: 9-16
18. Dhom G. Epidemiology of hormone-dependent tumors. In Voigt KD, Knabbe C eds. Endocrine Dependent Tumors. New York: Raven Press Ltd, 1991: 1-42
19. Boyle P. Evolution of an epidemic of unknown origin. In Denis L ed.. Prostate Cancer 2000, European School of Oncology Monograph. Heidelberg: Springer Verlag, 1994: 5-11
20. Boyle P, Maisonneuve P. Hormonal carcinogenesis. In Waxman J. ed., Diet. Cambridge University Press, 1995: In Press
21. World Health Organisation. Trends in prostate cancer 1980-1988. WHO Weekly Epidemiological Record 1992: 67: 281-8
22. Muir CS, Waterhouse JAH, Mack T, Powell J, Whelan S, eds. Cancer incidence in Five Continents, Vol V. IARC Scientific Publications. No.88. IARC Lyon. 1987
23. Zaridze DG, Boyle P. Cancer of the prostate: epidemiology and aetiology. Br J Urol 1987; 59: 493-503
24. Skeet RG. Epidemiology of urological tumours. In Williams DI, Chisholm GD eds, Scientific Foundations of Urology, Vol.11. London: William Heineman Medical Books, 1976: 199-211
25. Miller GJ. Diagnosis of stage A prostatic cancer in the People's Republic of China. In Coffey DS. Resnick MI, Dorr FA, Karr JP eds. A Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer. New York: Plenum Press. 1988: 17-24
26. Parkin DM. Muir CS, Whelan S. Gao YT, Ferlay J, Powell J, eds. Cancer incidence in five continents, Vol.V1. IARC Scientific Publication No.120, IARC Lyon, 1992.
27. Boyle P, Levi F. Lucchini F, La Vecchia. Trends in diet-related cancers in Japan: a conundrum. Lancet 1993; 342: 752
28. Burkitt DP. Epidemiology of cancer of the colon and rectum. Cancer 1971; 28: 3-13
29. Trowell HC, Burkitt DP. In Western diseases: Their Emergence and Prevention. London: Edward Arnold, 1983
30. Reddy BS, Cohen LA, eds. Diet, Nutrition and Cancer: A Critical Evaluation. Boca Raton: CRC Press. 1986
31. Rose DP. Dietary fibre, phytoestrogens, and breast cancer. Nutrition 1990; 8: 47-51
32. Trock B, Lanza E, Greenwald P. Dietary fibre, vegetables, and colon cancer: critical review and meta-analysis of the epidemiologic evidence. J Natl Cancer Inst 1990; 82: 650-61
33. Macquart-Moulin G, Riboli E, Cornee J, Charnay B, Berthezene P, Day N. Case-control study on colorectal cancer and diet in Marseilles. Int J Cancer 1986; 38: 183-91
34. Steinmetz K, Potter J. Vegetables, fruit and cancer. I. Epidemiology. Cancer Causes and Control 1991; 2: 325-57
35. Steinmetz K, Potter J. Vegetables, fruit and cancer. II. Mechanisms. Cancer Causes and Control 1991; 2: 427-42
36. Ingram DM, Nottage E, Roberts T. The role of diet in the development of breast cancer: a case-control study of patients with breast cancer, benign epithelial hyperplasia and fibrocystic disease of the breast. Br J Cancer 1991; 64: 187-91
37. Wynder EL, Mabuchi K, Whitmore WF. Epidemiology of cancer of the prostate. Cancer 1971: 28: 344-60
38. Boyle P, Zaridze DG. Risk factors for prostate and testicular cancer. Eur J Cancer 1993; 29A: 1048-55
39. Giovannuucci E, Rimm EB, Colditz GA et al. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 1993: 85: 1571-9
40. Mills PK. Beeson WL, Phillips RL, Frazer GE. Cohort study of diet, lifestyle and prostate cancer in Adventist men. Cancer 1989: 64: 598-604
41. Le Marchand L. Kolonel L. Wilkens LR, Myers BC, Hirohata T. Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology 1994; 5: 276-82
42. Severson RK, Nomura AM. Grove AS. Stemmerman GN. A prospective study of demographics, diet and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Research 1989: 49: 1857-60
43. Stemmerman GN. Nomura AM, Heilbrun LK. Cancer risk in relation to fat and energy intake among Hawaii Japanese: a prospective study. International Symposium of the Princess Takamatsu Cancer Research Fund 1985: 16: 265-74
44. Kolonel LN. Hankin JH, Nomura AM, Chu SY. Dietary fat intake and cancer incidence among five ethnic groups in Hawaii. Cancer Research 1981; 41: 3727-8
45. Kroes R, Beems RB, Bosland MC, Bunnick GS, Sinkeldam EJ. Nutritional factors in lung, colon and prostate cancer in animal models. Fed Proc 1986; 45: 136-41
46. Simopoulos AP. Nutritional cancer risks derived from energy and fat. Med Onco & Tumor Pharm 1987; 4: 227-39
47. Albanes D. Caloric intake, body weight and cancena review. Nutr Cancer 1987; 9: 199-217
48. Kolonel LN, Hankin JH, Yoshizawa CN. Vitamin A and prostate cancer in elderly men: enhancement of risk. Cancer Research 1987; 47: 2982-5
49. Paganini-Hill A, Chao A, Ross R, Henderson BE. Vitamin A, beta-carotene and risk of prostate cancer: a prospective study. J Natl Cancer Inst 1987; 79: 443-8
50. Hsing AW, McLauhglin JK, Schuman LM et al. Diet, tobacco use and fatal prostate cancer: results from the Lutheran Brotherhood Study. Cancer Research 1990; 50: 6836-40
51. Ross RK, Shimuzu H, Paganini-Hill A, Honda G, Henderson BE. Case-controlled studies of prostate cancer in blacks and whites in Southern California. J Natl Cancer Inst 1987; 78: 869-74
52. Ohno Y, Yoshida 0, Oishi K, Yamabe H, Schroeder FH. Dietary beta-carotene and cancer of the prostate: a case-controlled study in Kyoto, Japan. Cancer Research 1988; 48: 1331-6
53. Comstock GW, Helzouer KJ, Bush TL. Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland. Am } Clin Nutr 1991; 53 (Suppl. C): 260s-4s
54. Smith AH, Waller KD. Serum beta-carotene in persons with cancer and their immediate family. Am J Epidemiol 1991; 133: 661-71
55. Criqui MH, Bangdiwala S, Goodman DS et al. Selenium, retinol, retinol-binding protein and uric acid. Associations with cancer mortality in a population-based case-control study. Ann Epidemiol 1991; 1: 385-93
56. Hsing AW, Comstock GW, Abbey H, Polk BF. Serologic precursors of cancer. Retinol, carotenoids and tocopherol and risk of prostate cancer. J Natl Cancer Inst 1990: 82: 941-6
57. Reichmann ME, Hayes RB, Ziegler RG et al. Serum vitamin A and subsequent development of prostate cancer in the First National Health and Nutrition Examination Survey Epidemiologic Follow up Study. Cancer Research 1990; 50: 2311-5
58. Willett WC, Hunter DJ. Vitamin A and cancers of the breast, large bowel and prostate: epidemiological evidence. Nutr Rev 1994; 52: 853-9
59. Schwartz GG. Hulka BS. Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 1990; 10: 1307-11
60. Hanchette CL, Schwartz GG. Geographic patterns of prostate mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 1992; 70: 2861-9
61. Corder EH, Guess HA, Hulka BS et al. Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers and Prevention 1993; 2: 467-72
62. Peehl DM, Skowronski RJ, Leung GK, Wong ST, Stamey TA, Feldman D. Anti-proliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Research 1994; 54: 805-10
63. Anonymous. The effect vitamin E and beta-carotene on the incidence of lung cancer and other cancers in smokers. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. New Eng J Med 1995; 330; 1029-35
64. Hiatt RA, Armstrong MA, Klatsky AL, Sidney S. Alcohol consumption, smoking and other risk factors and prostate cancer in a large health plan cohort in California. Cancer Causes and Control 1994; 5: 66-72
65. Van Der Gulden JW, Verbeek AL, Klok JJ. Smoking and drinking habits in relation to prostate cancer. Br J Urol 1994; 73; 382-9
66. Stemmerman GN, Nomura AM, Chyou PH, Yoshizawa C. Prospective study of alcohol intake and large bowel cancer. Dig Dis and Sciences 1990; 35: 1414-20
67. Tavani A. Negri E, Franceschi S, Talamini R. La Vecchia C. Alcohol and risk of prostate cancer. Nutr & Cancer 1994; 21: 24-31
68. Yu H. Harris RE, Wynder EL. Case-control study of prostate cancer and socioeconomic factors. Prostate 1988: 13: 317-25
69. Tonneson H, Moller H, Andersen JR, Jensen E, Juel K. Cancer morbidity in alcohol abusers. Br J Cancer 1994; 69: 327-32
70. Hirayama T. A large scale cohort study on cancer risks by diet-with special reference to the risk reducing effects of green-yellow vegetable consumption. In Hayash Y et al. eds, Diet, Nutrition And Cancer. Tokyo/VNU Sci Press. Utrecht: Japan Sci Soc Press, 1986: 41-53
71. Hirayama T. Epidemiology of prostate cancer with special reference to the role of diet. Natl Cancer Inst Monographs 1979; 53: 149-55
72. Hirayama T. Life-style and cancer: from epidemiological evidence to public behaviour change to mortality reduction of target cancers. Monographs Natl Cancer Inst 1992; 12: 65-74
73. La Vecchia C, Negri E, Parazzini F. Marubini E, Trichopolous D. Diet and cancer risk in Northern Italy: an overview from various case-controlled studies. Tumori 1990; 76: 306-10
74. Lee HP. Gourley L, Duffy SW. Esteve J, Lee J, Day NE. Dietary effects on breast cancer risk in Singapore. Lancet 1991; 337: 1197-1200
75. Setchell KDR, Adlercreutz H. Mammalian lignans and phytooestrogens. Recent studies on their formation, metabolism and biological role in health and disease. In Roland IR ed. Role of Cut Flora in Toxicity and Cancer. London; Academic Press, 1988: 315-45
76. Kodama M, Kodama T. Interrelation between Western type cancers and non-Western type cancers as regards their risk variations in time and space. II Nutrition and cancer risk. Anticancer Res 1990: 10: 1043-9
77. Rose DP, Boyar AP, Wynder EL. International comparisons of mortality rates for cancer of the breast, ovary, prostate and colon and per capita food consumption. Cancer 1986; 58: 2363-71
78. Block G, Patterson B, Subar A. Fruit, vegetables and cancer prevention: a review of the epidemiological evidence. Nutrition & Cancer 1992; 18: 1-29
79. Negri E. La Vecchia C. Franceschi S, D'Avanzo B. Parazzini F. The role of vegetables and fruit in cancer risk. In Hill MJ. Giacosa A, Caygill CPJ eds. Epidemiology of Diet and Cancer. Chichester: Ellis Horwood, 1994: 327-34
80. Buiatti E, Palli D, De Carli A et al. A case-control study of gastric cancer and diet in Italy. Int J Cancer 1989; 44: 611-6
81. Buatti E. Palli D. De Carli A et al A case-control study of gastric cancer and diet in Italy. II. Association with nutrients. Int J Cancer 1990; 45: 896-901
82. La Vecchia C, De Carli A. Negri E, Parazzini F. Epidemiological aspects of diet and cancer: A summary review of case-control studies from Northern Italy. Oncology 1988: 45: 364-70
83. Bradbury RB, White DC. Oestrogens and related substances in plants. Vitam Horm 1954; 12: 207-33
84. Price KR, Fenwick GR. Naturally occurring oestrogens in food-a review. Food Add Contam 1985; 2: 73-106
85. Verdeal K, Brown RR. Richardson T. Ryan DS. Affinity of phytoestrogens for estradiol-binding proteins and effect of coumestrol on growth of 7.12-dimethylbenz(a) anthracene-induced rat mammary tumors. J Natl Cancer Inst 1980: 65: 285-90
86. Axelson M. Sjovall J. Gustafsson BE. Setchell KDR. A dietary source of the non-steroidal oestrogen equol in man and animals. J Endocrinol 1984: 102: 49-56
87. Walz E. Isoflavon-und Sapogenin-Glucoside in Sojahispida. Justus Liebigs Annal Chem 1931; 489: 118-55
88. Coward L. Barnes NC, Setchell KDR, Barnes S. Genistein, Daidzein, and their β-Glycoside conjugates : antitumor isoflavones in soybean foods from American and Asian diets. J Agric Food Chem 1993; 41: 1961-7
89. Rao CBS ed, The Chemistry of Lignons. Waltair, India: Andra University Press and Publications, 1978: 1 -377
90. Thompson LU, Robb P, Serraino M. Cheung F. Mammalian lignan production from various foods. Nutr Cancer 1991: 16:43-52
91. Kelly GE. Nelson C. Waring MA, Joannou GE. Reeder AY. Metabolites of dietary (soya) isoflavones in human urine. Clin Chim Acta 1993: 223: 9-22
92. Adlercreutz H. Fotsis T. Bannwart C et al. Determination of urinary lignans and phytooestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. J Steroid Biochem 1986: 25: 791-7
93. Morton MS. Wilcox G, Wahlqvist ML. Griffiths K. Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J Endocrinol 1994; 142: 251-9
94. Finlay EMH. Wilson DW. Adlercreutz H. Griffiths K. The identification and measurement of 'phyto-oestrogens' in human saliva, plasma, breast aspirate or cyst fluid, and prostatic fluid using gas chromatography-mass spectrometry. J Endocrinol 1991; 129 (suppl): 49
95. Dehennin L, Reiffsteck A, Joudet M, Thibier M. Identification and quantitative estimation of a lignan in human and bovine semen. J Reprod Pert 1982; 66: 305-9
96. Adlercreutz H, Honjo H, Higashi A et al. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming traditional Japanese diet. Am J Clin Nutr 1991; 54: 1093-100
97. Adlercreutz H. Markkanen H. Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993; 342: 1209-10
98. Setchell KDR, Bordello SP, Hulme P, Kirk DN, Axelson M. Nonsteroidal oestrogens of dietary origin: Possible roles in hormone-dependent disease. Am J Clin Nutr 1984: 40: 569-78
99. Pope GS. Wright HG. Oestrogenic isoflavones in red clover and subterranean clover. Chem & Ind 1954: 1019-20
100. Bickoff EM. Estrogen-like substances in plants. In Hissaw FL ed. Physiology of Reproduction, Proc. 22nd. Animal Biology Colloquium. Corvallis: Oregon State Univ Press. 1961: 93-118
101. Waters AP. Knowler JT. Effect of a lignan (HPMF) on RNA synthesis in the rat uterus. J Reprod Pert 1982: 66: 379-81
102. Martin PM. Horwitz KB. Ryan DS. McGuire WL. Phytooestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 1978; 103: 1860-7
103. Adlercreutz H, Hockerstedt K, Bann wart C et al. Effect of dietary components, including lignans and phytoestrogens on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J Steroid Biochem 1987; 27: 1135-44
104. Cunha GR. Chung LWK, Shannon JM, Taguchi 0, Fujii H. Hormone-induced morphogenesis and growth: Role of mesenchymal-epithelial interaction. Recent Prog Horm Res 1983; 39: 559-95
105. Griffiths K. Davies P. Eaton CL, Harper ME. Turkes A. Peeling WB. Endocrine factors in the initiation, diagnosis and treatment of prostatic cancer. In Voigt KD. Knabbe C eds. Endocrine Dependent Tumors. New York: Raven Press. 1991: 83-130
106. Coffey DS. In Khoury S. Chatelain C. Murphy G. Denis L. eds. The Structure and Function of the Prostate Gland and Sex Accessery Tissues in Prostate Cancer. Paris: FUS Publ. 1990: 70-103
107. Griffiths K, Davies P. Eaton CL et al. Cancer of the prostate: endocrine factors. In Clark JR ed., Oxford Reviews of Reproductive Biology, Vol.9. Oxford: Clarendon Press. 1987: 192-259
108. Vermeulen A. Rubens R, Verdonck L. Testosterone secretion and metabolism in male senescence. J Clin Endoc Metab 1972; 34: 730-5
109. Rubens R. Dhont M. Vermeulen A. Further studies on Leydig cell function in old age. J Clin Endoc Metab 1974: 39: 40-5
110. Vermeulen A. van Camp A. Mattelaer J. De Sy W. Hormonal factors related to abnormal growth of the prostate. In Coffey DS, Isaacs JT eds, Prostate Cancer. Geneva: UICC Technical Workshop Series, Vol.48, UICC, 1979: 81-92
111. Belanger A, Locong A, Noel C et al. Influence of diet on plasma steroids and sex hormone-binding globulin levels in adult men. J Steroid Biochem 1989; 32: 829-33
112. Vermeulen A. Metabolic effects of obesity in men. Verhandelingen-Koninklijke Academie Voor Geneeskunde Van Belgie 1993; 55: 393-7
113. Griffiths K. Akaza H, Eaton CL et al. Regulation of prostatic growth. In Cockett ATK. Khoury S, Aso Y et al. eds. The 2nd International Consultation on Benign Prostatic Hyperplasia (BPH). Paris: SCI, 1993: 49-75
114. Bruchovsky N. Wilson JD. The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro. J Biol Chem 1968; 243: 2012-21
115. Bruchovsky N, Wilson JD. The intranuclear binding of testosterone and 5-alpha-androstan-17-beta-ol-3-one by rat prostate. J Biol Chem 1968; 243: 5953-60
116. Anderson KH, Liao S. Selective Retention of Dihydrotestosterone by Prostatic Nuclei. Nature (London) 1968; 219: 277-9
117. Komoda Y. Isolation of flavonoids from Populus nigra as delta 4-3-ketosteroid (5a) reductase inhibitors. Chem Pharm Bull 1989; 37: 3128-30
118. Liang T, Liao S. Inhibition of steroid 5 alpha-reductase by specific aliphatic unsaturated fatty acids. Biochem J 1992; 285: 557-62
119. Evans BAJ, Griffiths K, Morton M. Inhibition of 5α-reductase and 17β-hydroxysteroid dehydrogenase in genital skin fibroblasts by dietary lignans and isoflavonoids. J Endocrinol 1995; 147: 295-302
120. Ross RK, Bernstein L, Lobo RA et al. 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet 1992; 339: 887-9
121. Rittmaster RS. Finasteride. New Eng J Med 1994; 330: 120-5
122. Vermeulen A. Testicular hormone secretion and aging in males. In Grayshack JT, Wilson JD, Saherbenske MJ eds. Benign Prostatic Hyperplasia. DHEW Publ. No. (NIH) 76-1113, 1976: 177-82
123. Vermeulen A, Deslypere JP, Meirleir K. A new look to the andropause: altered function of the gonadotrophs. J Steroid Biochem 1989; 32: 163-5
124. Kellis JT, Vickery LE. Inhibition of human estrogen synthetase (aromatase) by flavones. Science 1984; 225: 1032-4
125. Kellis JT, Nesnow S, Vickery LE. Inhibition of aromatase cytochrome P-450 (estrogen synthetase) by derivatives of a-naphthoflavone. Biochem Pharmac 1986; 35: 2887-91
126. Ibrahim AR, Abul-Hajj YJ. Aromatase inhibition by flavonoids. J Steroid Biochem Molec Biol 1990; 37: 257-60
127. Adlercreutz H, Bannwart C, Wahala K et al. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Molec Biol 1993; 44: 147-53
128. Campbell DR, Kurzer MS. Flavonoid inhibition of aromat-ase enzyme activity in human preadipocytes. J Steroid Biochem Molec Biol 1993; 46: 381-8
129. Evans BAJ, Griffiths K, Morton M. Inhibition of aromatase in human genital skin fibroblasts by dietary isoflavonoids and lignans. J Enzyme Inhib 1995: in press
130. Hunter T, Cooper JA. Protein tyrosine kinases. Ann Review Biochem 1985; 54: 897-930
131. Bishop JM. Cellular oncogenes and retroviruses. Annu Review Biochem 1985; 52: 301-54
132. Schlessinger J, Schreiber AB, Levi A, Lax J, Liberman T, Yarder Y. Regulation of cell proliferation by epidermal growth factor. Crit Rev Biochem 1983; 14: 93-111
133. Kenyon GL, Garcia G A. Design of kinase inhibitors. Med Res Rev 1987; 7: 389-416
134. Akiyama T, Ishida J, Nakagawa S et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987; 262: 5592-5
135. Kiguchi K, Glesne D, Chubb CH, Fujiki H, Huberman E. Differential induction of apoptosis in human breast cells by okadaic acid and related inhibitors of protein phosphatases 1 and 2A. Cell Growth Diff 1994; 5: 995-1004
136. Scholar EM, Toews ML. Inhibition of invasion of murine mammary carcinoma cells by the tyrosine kinase inhibitor genistein. Cancer Lett 1994; 87: 159-62
137. Tiisala S, Majuri ML, Carpen 0, Renkonen R. Genistein enhances the ICAM-mediated adhesion by inducing the expression of ICAM-1 and its counter receptors. Biochem Biophys Res Comm 1994; 203: 443-9
138. Spinozzi F, Pagliacci MC, Migliorati G et al. The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells. Leuk Res 1994; 18: 431-9
139. Matsukawa Y, Marui N, Sakai T et al Genistein arrests cell cycle progression at G2-M. Cancer Res 1993; 53: 1328-31
140. McCabe MJ Jr., Orrenius S. Genistein induces apoptosis in immature human thymocytes by inhibiting topoisomerase-II. Biochem Biophys Res Comm 1993; 194: 944-50
141. Fotsis T, Pepper M, Adlercreutz H et al. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci 1993; 90: 2690-4
142. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339: 58-61
143. Folkman J. Toward an understanding of angiogenesis : search and discovery. Perspectives in Biol Med 1985; 29: 10-36
144. Weidner M, Semple JP, Welch WR, Folkman J. Tumour angiogenesis and metaplasia-correlation in invasive breast cancer. New Eng J Med 1991; 324: 1-8
145. Sharma OP, Adlercreutz H, Strandberg JD, Zirkin B, Coffey DS, Ewing LL. Soy of dietary source plays a preventive role against the pathogenesis of prostatitis in rats. J Steroid Biochem Mol Biol 1992: 43: 557-63
146. Lundgren R, Holmquist B, Hesselvik M, Muntzing J. Treatment of prostatitis in the rat. Prostate 1984; 5: 277-84
147. Naslund MJ, Strandberg JD, Coffey DS. The role of androgens and estrogens in the pathogenesis of experimental nonbacterial prostatitis. J Urol 1988; 140: 1049-53
148. Drane HM, Patterson DSP, Roberts BA, Saba N. The chance discovery of oestrogenic activity in laboratory rat cake. Food Cosmet Toxicol 1975; 13: 491-2
149. Adlercreutz H, Hamalainen E, Gorbach S. Goldin B. Dietary phyto-oestrogens and the menopause in Japan. Lancet 1992; 339; 1233